Literature DB >> 26797286

Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options.

Robert H Fryer1, Jennifer M Bain2, Darryl C De Vivo2.   

Abstract

IMPORTANCE: Stroke-like episodes signal progression and significant disability in the mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes syndrome. Arginine is widely used as a treatment for stroke-like episode, although there is little evidence for this intervention. We discuss the management of a patient with mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes who presented with a stroke-like episode. OBSERVATION: During a seizure, which triggers the stroke-like episode, neurons are forced to utilize glycolysis as a source of adenosine triphosphate. Glycolytic by-products are damaging to the neuron. Breakdown of the blood-brain barrier leads to vasogenic edema.
CONCLUSION: Treatment of stroke-like episode should include anticonvulsants interictally to prevent seizures and dexamethasone ictally to help repair the blood-brain barrier.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MELAS; arginine; aspirin; glycolysis; lactic acidosis; mitochondria; seizures; stroke-like episode

Mesh:

Substances:

Year:  2015        PMID: 26797286      PMCID: PMC4789111          DOI: 10.1016/j.pediatrneurol.2015.12.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  29 in total

Review 1.  Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.

Authors:  Kristin M Santa
Journal:  Pharmacotherapy       Date:  2010-11       Impact factor: 4.705

2.  Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging.

Authors:  M Yoneda; M Maeda; H Kimura; A Fujii; K Katayama; M Kuriyama
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Inappropriate intracranial hemodynamics in the natural course of MELAS.

Authors:  Junko Nishioka; Yukihiro Akita; Shuichi Yatsuga; Koujyu Katayama; Toyojiro Matsuishi; Masatoshi Ishibashi; Yasutoshi Koga
Journal:  Brain Dev       Date:  2007-07-30       Impact factor: 1.961

4.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

5.  Cerebral hyperperfusion and decreased cerebrovascular reactivity correlate with neurologic disease severity in MELAS.

Authors:  L H Rodan; J Poublanc; J A Fisher; O Sobczyk; T Wong; E Hlasny; D Mikulis; I Tein
Journal:  Mitochondrion       Date:  2015-03-21       Impact factor: 4.160

Review 6.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome.

Authors:  T Iizuka; F Sakai; N Suzuki; T Hata; S Tsukahara; M Fukuda; Y Takiyama
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

8.  Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.

Authors:  Ayman W El-Hattab; Jean W Hsu; Lisa T Emrick; Lee-Jun C Wong; William J Craigen; Farook Jahoor; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2012-01-24       Impact factor: 4.797

9.  Role of glutamate in neuron-glia metabolic coupling.

Authors:  Pierre J Magistretti
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

Review 10.  Methylglyoxal, the dark side of glycolysis.

Authors:  Igor Allaman; Mireille Bélanger; Pierre J Magistretti
Journal:  Front Neurosci       Date:  2015-02-09       Impact factor: 4.677

View more
  7 in total

1.  Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note.

Authors:  Han Som Choi; Jae Hyun Lee; Sun Ho Lee; Young-Mock Lee
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

2.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Authors:  Rohit Sharma; Bryn Reinstadler; Kristin Engelstad; Owen S Skinner; Erin Stackowitz; Ronald G Haller; Clary B Clish; Kerry Pierce; Melissa A Walker; Robert Fryer; Devin Oglesbee; Xiangling Mao; Dikoma C Shungu; Ashok Khatri; Michio Hirano; Darryl C De Vivo; Vamsi K Mootha
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

3.  l-Arginine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes: A Systematic Review.

Authors:  Renae J Stefanetti; Yi Shiau Ng; Linda Errington; Alasdair P Blain; Robert McFarland; Gráinne S Gorman
Journal:  Neurology       Date:  2022-04-15       Impact factor: 11.800

4.  MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach.

Authors:  Sara Seitun; Laura Massobrio; Anna Rubegni; Claudia Nesti; Margherita Castiglione Morelli; Sara Boccalini; Athena Galletto Pregliasco; Irilda Budaj; Luca Deferrari; Gian Marco Rosa; Fabrizio Montecucco; Alberto Valbusa
Journal:  Case Rep Cardiol       Date:  2016-11-07

Review 5.  Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Masamichi Ikawa; Nataliya Povalko; Yasutoshi Koga
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2020-01       Impact factor: 3.620

6.  L-Arginine Reduces Nitro-Oxidative Stress in Cultured Cells with Mitochondrial Deficiency.

Authors:  Camila D S Barros; Jomênica B Livramento; Margaret G Mouro; Elisa Mieko Suemitsu Higa; Carlos T Moraes; Celia Harumi Tengan
Journal:  Nutrients       Date:  2021-02-06       Impact factor: 5.717

7.  Visual memory failure presages conversion to MELAS phenotype.

Authors:  Emily B Leaffer; Darryl C De Vivo; Kristin Engelstad; Robert H Fryer; Yian Gu; Dikoma C Shungu; Michio Hirano; Salvatore DiMauro; Veronica J Hinton
Journal:  Ann Clin Transl Neurol       Date:  2022-05-06       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.